GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Shiller PE Ratio

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Shiller PE Ratio : (As of Apr. 26, 2024)


View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


IntelliPharmaCeutics International Shiller PE Ratio Historical Data

The historical data trend for IntelliPharmaCeutics International's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Shiller PE Ratio Chart

IntelliPharmaCeutics International Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

IntelliPharmaCeutics International Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IntelliPharmaCeutics International's Shiller PE Ratio

For the Biotechnology subindustry, IntelliPharmaCeutics International's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Shiller PE Ratio falls into.



IntelliPharmaCeutics International Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

IntelliPharmaCeutics International's E10 for the quarter that ended in Aug. 2023 is calculated as:

For example, IntelliPharmaCeutics International's adjusted earnings per share data for the three months ended in Aug. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Aug. 2023 (Change)*Current CPI (Aug. 2023)
=-0.06/125.3885*125.3885
=-0.060

Current CPI (Aug. 2023) = 125.3885.

IntelliPharmaCeutics International Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201311 -3.100 97.182 -4.000
201402 0.900 98.051 1.151
201405 -1.400 99.394 -1.766
201408 -0.700 99.315 -0.884
201411 -0.600 99.078 -0.759
201502 -0.400 99.078 -0.506
201505 -0.600 100.263 -0.750
201508 -0.800 100.579 -0.997
201511 -1.300 100.421 -1.623
201602 -0.900 100.421 -1.124
201605 -0.800 101.765 -0.986
201608 -0.700 101.686 -0.863
201611 -1.400 101.607 -1.728
201702 -0.700 102.476 -0.857
201705 -0.600 103.108 -0.730
201708 -0.830 103.108 -1.009
201711 -0.770 103.740 -0.931
201802 -0.910 104.688 -1.090
201805 -0.070 105.399 -0.083
201808 -0.910 106.031 -1.076
201811 -0.400 105.478 -0.476
201902 -0.160 106.268 -0.189
201905 -0.100 107.927 -0.116
201908 -0.070 108.085 -0.081
201911 -0.050 107.769 -0.058
202002 -0.080 108.559 -0.092
202005 -0.040 107.532 -0.047
202008 0.040 108.243 0.046
202011 -0.060 108.796 -0.069
202102 -0.040 109.745 -0.046
202105 -0.040 111.404 -0.045
202108 -0.040 112.668 -0.045
202111 -0.060 113.932 -0.066
202202 -0.030 115.986 -0.032
202205 -0.030 120.016 -0.031
202208 -0.010 120.569 -0.010
202211 -0.020 121.675 -0.021
202302 -0.010 122.070 -0.010
202305 -0.002 124.045 -0.002
202308 -0.060 125.389 -0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IntelliPharmaCeutics International  (OTCPK:IPCIF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


IntelliPharmaCeutics International Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Headlines